Duration of antibody responses after severe acute respiratory syndrome

被引：295
作者：
Wu, Li-Ping
Wang, Nai-Chang
Chang, Yi-Hua
Tian, Xiang-Yi
Na, Dan-Yu
Zhang, Li-Yuan
Zheng, Lei
Lan, Tao
Wang, Lin-Fa
Liang, Guo-Dong [1 ]
机构：
[1] Shanxi Prov Ctr Dis Control & Prevent, Taiyuan, Peoples R China
[2] Shanxi Prov Peoples Hosp, Taiyuan, Peoples R China
[3] CSIRO, Australian Anim Hlth Lab, Geelong, Vic, Australia
[4] Australian Biosecurity Ctr Emerging Infect Dis, Geelong, Vic, Australia
[5] State Key Lab Infect Dis Control & Prevent, Beijing, Peoples R China
来源：
EMERGING INFECTIOUS DISEASES | 2007年 / 13卷 / 10期
关键词：
D O I：
10.3201/eid1310.070576
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Among 176 patients who had had severe acute respiratory syndrome (SARS), SARS-specific antibodies were maintained for an average of 2 years, and significant reduction of immunoglobulin G-positive percentage and titers occurred in the third year. Thus, SARS patients might be susceptible to reinfection >= 3 years after initial exposure.
引用
收藏
页码：1562 / 1564
页数：3
相关论文
共 15 条
  • [11] Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human
    Song, HD
    Tu, CC
    Zhang, GW
    Wang, SY
    Zheng, K
    Lei, LC
    Chen, QX
    Gao, YW
    Zhou, HQ
    Xiang, H
    Zheng, HJ
    Chern, SWW
    Cheng, F
    Pan, CM
    Xuan, H
    Chen, SJ
    Luo, HM
    Zhou, DH
    Liu, YF
    He, JF
    Qin, PZ
    Li, LH
    Ren, YQ
    Liang, WJ
    Yu, YD
    Anderson, L
    Wang, M
    Xu, RH
    Wu, XW
    Zheng, HY
    Chen, JD
    Liang, GD
    Gao, Y
    Liao, M
    Fang, L
    Jiang, LY
    Li, H
    Chen, F
    Di, B
    He, LJ
    Lin, JY
    Tong, SX
    Kong, XG
    Du, L
    Hao, P
    Tang, H
    Bernini, A
    Yu, XJ
    Spiga, O
    Guo, ZM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (07) : 2430 - 2435
  • [12] Longitudinally profiling neutralizing antibody response to SARS coronavirus with pseudotypes
    Temperton, NJ
    Chan, PK
    Simmons, G
    Zambon, MC
    Tedder, RS
    Takeuchi, Y
    Weiss, RA
    [J]. EMERGING INFECTIOUS DISEASES, 2005, 11 (03) : 411 - 416
  • [13] Wang LF, 2006, EMERG INFECT DIS, V12, P1834
  • [14] Longitudinal profile of immunoglobulin G (IgG), IgM, and TgA antibodies against the severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in patients with pneumonia due to the SARS coronavirus
    Woo, PCY
    Lau, SKP
    Wong, BHL
    Chan, KH
    Chu, CM
    Tsoi, HW
    Huang, Y
    Peiris, JSM
    Yuen, KY
    [J]. CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2004, 11 (04) : 665 - 668
  • [15] Word Health Organization, 2003, CAS DEF SURV SEV AC
12